ALPINE IMMUNE SCIENCES INC (ALPN) Stock Analyst Earnings Estimates
NASDAQ:ALPN - Nasdaq - US02083G1004 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23.44M 150.96% | 30.06M 28.24% | 58.876M 95.86% | 15.939M -72.93% | 16.653M 4.48% | 10.132M -39.16% | 45.538M 349.45% | 156.26M 243.14% | 511.79M 227.52% | 959.36M 87.45% | 1.709B 78.14% | |
| EBITDA YoY % growth | -49.24M -74.80% | -57.55M -16.88% | -43.674M 24.11% | -108.972M -149.51% | -142.068M -30.37% | -161.84M -13.92% | -189.414M -17.04% | -199.92M -5.55% | N/A | N/A | N/A | |
| EBIT YoY % growth | -49.86M -73.43% | -58.15M -16.63% | -44.25M 23.90% | -111.373M -151.69% | -128.213M -15.12% | -163.888M -27.82% | -173.447M -5.83% | -82.57M 52.39% | 283.04M 442.79% | 755.16M 166.80% | 1.358B 79.83% | |
| Operating Margin | -212.71% | -193.45% | -75.16% | -698.74% | -769.91% | -1,617.52% | -380.88% | -52.84% | 55.30% | 78.71% | 79.46% | |
| EPS YoY % growth | -1.98 -43.48% | -1.68 15.15% | -0.67 60.12% | -1.73 -157.63% | -1.95 -12.70% | -2.48 -27.72% | -2.32 6.63% | -1.25 46.04% | 2.91 332.52% | 7.63 162.15% | 15.18 98.90% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -52.53% | -0.44 -82.96% | -0.40 -435.87% | -0.53 -89.43% | -0.54 -31.27% | -0.52 -18.47% | -0.53 -31.60% |
| Revenue Q2Q % growth | 3.559M -58.58% | 3.572M -64.43% | 5.328M -82.73% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -32.232M -109.57% | -34.68M -145.61% | -37.332M -1,858.46% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.16M -67.05% | -27.951M -92.10% | -27.726M -1,892.22% | -33.214M -46.34% | -34.101M -30.35% | -35.016M -25.28% | -35.96M -29.70% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.28 | -0.42 | 0.14 | 33.62% |
| Q4 2023 Q2Q % growth | 0.12 129.27% | -0.34 | 0.46 | 135.04% |
| Q3 2023 Q2Q % growth | -0.24 42.86% | -0.34 | 0.10 | 29.64% |
| Q2 2023 Q2Q % growth | -0.27 55.00% | -0.38 | 0.11 | 29.29% |
| Q1 2023 Q2Q % growth | -0.28 -12.00% | -0.38 | 0.10 | 25.93% |
| Q4 2022 Q2Q % growth | -0.41 21.15% | -0.27 | -0.14 | -49.99% |
| Q3 2022 Q2Q % growth | -0.42 23.64% | -0.10 | -0.32 | -301.72% |
| Q2 2022 Q2Q % growth | -0.60 -30.43% | -0.40 | -0.20 | -49.87% |
| Q1 2022 Q2Q % growth | -0.25 44.44% | -0.19 | -0.06 | -30.72% |
| Q4 2021 Q2Q % growth | -0.52 -92.59% | -0.31 | -0.21 | -67.15% |
| Q3 2021 Q2Q % growth | -0.55 -96.43% | 0.01 | -0.56 | -10,884.31% |
| Q2 2021 Q2Q % growth | -0.46 13.21% | -0.40 | -0.06 | -13.88% |
| Q1 2021 Q2Q % growth | -0.45 -50.00% | -0.36 | -0.09 | -23.69% |
| Q4 2020 Q2Q % growth | -0.27 18.18% | -0.32 | 0.05 | 15.07% |
| Q3 2020 Q2Q % growth | -0.28 54.84% | -0.24 | -0.04 | -18.07% |
| Q2 2020 Q2Q % growth | -0.53 17.19% | 0.55 | -1.08 | -197.12% |
| Q1 2020 Q2Q % growth | -0.30 57.14% | -0.48 | 0.18 | 37.42% |
| Q4 2019 Q2Q % growth | -0.33 | -0.60 | 0.27 | 44.70% |
| Q3 2019 Q2Q % growth | -0.62 | -0.69 | 0.07 | 10.61% |
| Q2 2019 Q2Q % growth | -0.64 | -0.69 | 0.05 | 7.39% |
| Q1 2019 Q2Q % growth | -0.70 | -0.70 | 0.00 | 0.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 7.032M -25.09% | 3.586M | 3.446M | 96.10% |
| Q4 2023 Q2Q % growth | 30.853M 1,009.82% | 9.286M | 21.567M | 232.25% |
| Q3 2023 Q2Q % growth | 10.043M 19.99% | 7.394M | 2.649M | 35.83% |
| Q2 2023 Q2Q % growth | 8.593M 62.44% | 9.027M | -434K | -4.81% |
| Q1 2023 Q2Q % growth | 9.387M -31.13% | 8.772M | 615K | 7.01% |
| Q4 2022 Q2Q % growth | 2.78M -38.63% | 11.184M | -8.404M | -75.14% |
| Q3 2022 Q2Q % growth | 8.37M -1.76% | 19.059M | -10.689M | -56.08% |
| Q2 2022 Q2Q % growth | 5.29M -26.43% | 10.245M | -4.955M | -48.37% |
| Q1 2022 Q2Q % growth | 13.63M 325.94% | 16.589M | -2.959M | -17.84% |
| Q4 2021 Q2Q % growth | 4.53M -19.68% | 14.249M | -9.719M | -68.21% |
| Q3 2021 Q2Q % growth | 8.52M 346.07% | 21.611M | -13.091M | -60.58% |
| Q2 2021 Q2Q % growth | 7.19M 942.03% | 6.606M | 584K | 8.84% |
| Q1 2021 Q2Q % growth | 3.2M 193.58% | 5.671M | -2.471M | -43.57% |
| Q4 2020 Q2Q % growth | 5.64M 540.91% | 2.639M | 3.001M | 113.72% |
| Q3 2020 Q2Q % growth | 1.91M 558.62% | 16.399M | -14.489M | -88.35% |
| Q2 2020 Q2Q % growth | 690K 21.05% | 16.93M | -16.24M | -95.92% |
| Q1 2020 Q2Q % growth | 1.09M | 384.203K | 705.797K | 183.70% |
| Q4 2019 Q2Q % growth | 880K | 186.997K | 693.003K | 370.60% |
| Q3 2019 Q2Q % growth | 290K | 191.25K | 98.75K | 51.63% |
| Q2 2019 Q2Q % growth | 570K | 63.75K | 506.25K | 794.12% |
| Q1 2019 Q2Q % growth | 51K | -51K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.87% | -9.12% | 0% | -26.02% |
| Revenue | 0% | -35.09% | 0% | -48.45% |